Lathosterol-to-cholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, single-blind placebo-controlled trial

American Journal of Clinical Nutrition

Volumn 101, Issue 3, 2015, Pages 432-439

  Mackay, Dylan S ^a,b   Gebauer, Sarah K ^c   Eck, Peter K ^a,b   Baer, David J ^c   Jones, Peter J H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cholesterol lowering; Interindividual variability; Noncholesterol sterols; Plant sterols; Randomized controlled trial

Indexed keywords

CAMPESTEROL; CHOLESTANOL; CHOLESTEROL; DESMOSTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; HYPOCHOLESTEROLEMIC AGENT; LATHOSTEROL; MARGARINE; PHYTOSTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LATHOSTEROL TO CHOLESTEROL RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; ALGORITHM; BIOSYNTHESIS; BLOOD; CANADA; CLINICAL TRIAL; DIET THERAPY; DOWN REGULATION; METABOLISM; MIDDLE AGED; UNITED STATES;

ADULT; AGED; ALGORITHMS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOWN-REGULATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MANITOBA; MARGARINE; MARYLAND; MIDDLE AGED; PHYTOSTEROLS; SINGLE-BLIND METHOD;

EID: 84928436951     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.095356     Document Type: Article

References (45)

1. Akihisa T, Kokke W, Tamura T. Naturally occuring sterols and related compounds from plants. In: Patterson GW, Nes WD, editors. Physiology and biochemistry of sterols. Champaign (IL): American Oil Chemists Society; 1991. p. 172-228.
2. Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009;139:271-84.
3. Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008;52;1811-28.
4. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003;78:965-78.
5. Ostlund RE Jr. Phytosterols, cholesterol absorption and healthy diets. Lipids 2007;42:41-5.
6. De Smet E, Mensink RP, Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: Suggested mechanisms from past to present. Mol Nutr Food Res 2012;56:1058-72.
7. Rideout TC, Chan YM, Harding SV, Jones PJ. Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies. Lipids Health Dis 2009;8:45.
8. Jakulj L, Trip MD, Sudhop T, von Bergmann K, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005;46:2692-8.
9. Casas-Agustench P, Serra M, Perez-Heras A, Cofan M, Pinto X, Trautwein EA, Ros E. Effects of plant sterol esters in skimmed milk and vegetable-fat-enriched milk on serum lipids and non-cholesterol sterols in hypercholesterolaemic subjects: a randomised, placebocontrolled, crossover study. Br J Nutr 2012;107:1766-75.
10. Rideout TC. Getting personal: considering variable interindividual responsiveness to dietary lipid-lowering therapies. Curr Opin Lipidol 2011;22:37-42.
11. Plat J, Mackay D, Baumgartner S, Clifton PM, Gylling H, Jones PJ. Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting. Atherosclerosis 2012;225:521-33.
12. Rudkowska I, AbuMweis SS, Nicolle C, Jones PJ. Association between non-responsiveness to plant sterol intervention and polymorphisms in cholesterol metabolism genes: a case-control study. Appl Physiol Nutr Metab 2008;33:728-34.
13. Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;29:1149-55.
14. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31.
15. Matthan NR, Raeini-Sarjaz M, Lichtenstein AH, Ausman LM, Jones PJ. Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women. Lipids 2000;35:1037-44.
16. Nissinen MJ, Gylling H, Miettinen TA. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Br J Nutr 2008;99:370-8.
17. Mackay DS, Jones PJ. Plasma noncholesterol sterols: current uses, potential and need for standardization. Curr Opin Lipidol 2012;23:241-7.
18. Miettinen TA, Gylling H, Nissinen MJ. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 2011;21:765-9.
19. Fuentes F, Lopez-Miranda J, Garcia A, Perez-Martinez P, Moreno J, Cofan M, Caballero J, Paniagua JA, Ros E, Perez-Jimenez F. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia. Eur J Clin Nutr 2008;62:495-501.
20. Carr TP, Krogstrand KL, Schlegel VL, Fernandez ML. Stearate-enriched plant sterol esters lower serum LDL cholesterol concentration in normoand hypercholesterolemic adults. J Nutr 2009;139:1445-50.
21. Mussner MJ, Parhofer KG, Von Bergmann K, Schwandt P, Broedl U, Otto C. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 2002;51:189-94.
22. Houweling AH, Vanstone CA, Trautwein EA, Duchateau GS, Jones PJ. Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food. Eur J Clin Nutr 2009;63:543-51.
23. Thuluva SC, Igel M, Giesa U, Lutjohann D, Sudhop T, von Bergmann K. Ratio of lathosterol to campesterol in serum predicts the cholesterollowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005;43:305-10.
24. Rideout TC, Harding SV, Mackay D, Abumweis SS, Jones PJ. High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am J Clin Nutr 2010; 92:41-6.
25. Santosa S, Varady KA, AbuMweis S, Jones PJ. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? Life Sci 2007;80:505-14.
26. Turley SD, Dietschy JM. The intestinal absorption of biliary and dietary cholesterol as a drug target for lowering the plasma cholesterol level. Prev Cardiol 2003;6:29-33, 64.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
28. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000;41:697-705.
29. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011;9:48.
30. Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Obes Res 2003;11:591-6.
31. Cofán M, Escurriol V, Garcia-Otin AL, Moreno-Iribas C, Larranaga N, Sanchez MJ, Tormo MJ, Redondo ML, Gonzalez CA, Corella D, et al. Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study. Nutr Metab Cardiovasc Dis 2011;21:651-7.
32. Lupattelli G, Pirro M, Mannarino MR, Siepi D, Roscini AR, Schillaci G, Mannarino E. Visceral fat positively correlates with cholesterol synthesis in dyslipidaemic patients. Eur J Clin Invest 2012;42:164-70.
33. Nunes VS, Leanca CC, Panzoldo NB, Parra E, Cazita PM, Nakandakare ER, de Faria EC, Quintao EC. HDL-C concentration is related to markers of absorption and of cholesterol synthesis: study in subjects with low vs. high HDL-C. Clin Chim Acta 2011;412:176-80.
34. Gylling H, Hallikainen M, Pihlajamaki J, Simonen P, Kuusisto J, Laakso M, Miettinen TA. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM study. J Lipid Res 2010;51:2422-7.
35. Van Rooyen DM, Farrell GC. SREBP-2: A link between insulin resistance, hepatic cholesterol, and inflammation in NASH. J Gastroenterol Hepatol 2011;26:789-92.
36. Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2007;16: 624-31.
37. Hernández-Mijares A, Banuls C, Jover A, Sola E, Bellod L, Martinez-Triguero ML, Lagarda MJ, Victor VM, Rocha M. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome. Clin Nutr 2011;30:604-9.
38. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 2014;371:2383-93.
39. Demonty I, Ras RT, van der Knaap HC, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials. Eur J Nutr 2013;52: 153-60.
40. Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008;27:117-26.
41. MacKay DS, Jones P. Limitations of lathosterol to plant sterol ratios and serum plant sterols as surrogate markers for cholesterol absorption during plant sterol supplementation. Nutr Metab Cardiovasc Dis 2012; 22:e21.
42. Vanstone CA, Jones PJ. Limitations of plasma plant sterols as indicators of cholesterol absorption. Am J Clin Nutr 2004;79:340-1.
43. De Castro-Orós I, Pampin S, Cofan M, Mozas P, Pinto X, Salas-Salvado J, Rodriguez-Rey JC, Ros E, Civeira F, Pocovi M. Promoter variant -204A > C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr 2011; 30:239-46.
44. Lottenberg AM, Nunes VS, Nakandakare ER, Neves M, Bernik M, Lagrost L, dos Santos JE, Quintao E. The human cholesteryl ester transfer protein I405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters. J Nutr 2003;133:1800-5.
45. Zhao HL, Houweling AH, Vanstone CA, Jew S, Trautwein EA, Duchateau GS, Jones PJ. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Lipids 2008;43:1155-64.